Benzinga - U.S. stocks traded lower, with the Nasdaq Composite falling over 100 points on Monday. Here are some big stocks recording gains in today’s session.
- Ebix, Inc. (NASDAQ: EBIX) jumped 31.6% to $17.17. Ebix named executive Amit K. Garg as CFO effective April 21. EbixCash Limited, a subsidiary of Ebix, received Securities and Exchange Board of India clearance for its proposed initial public offering.
- TG Therapeutics, Inc. (NASDAQ: TGTX) jumped 18.4% to $18.33. TG Therapeutics recently reported positive CHMP opinion for BRIUMVI (ublituximab-xiiy) for treatment of relapsing forms of multiple sclerosis in adults.
- EHang Holdings Limited (NASDAQ: EH) climbed 14.4% to $10.56.
- Syneos Health, Inc. (NASDAQ: SYNH) rose 13% to $39.44.
- Emergent BioSolutions Inc. (NYSE: EBS) gained 12.3% to $11.86 after Benchmark upgraded the stock from Hold to Buy.
- The Greenbrier Companies, Inc. (NYSE: GBX) surged 11.6% to $33.72 after the company reported better-than-expected Q2 sales results and raised guidance.
- Montauk Renewables, Inc. (NASDAQ: MNTK) gained 9.3% to $7.45.
- POSCO Holdings Inc. (NYSE: PKX) surged 9.1% to $74.11.
- Virgin Galactic Holdings, Inc. (NYSE: SPCE) rose 8.5% to $3.42. Virgin Orbit recently said it filed for voluntary Chapter 11 bankruptcy in order to effectuate a sale of its business.
- Western Digital Corporation (NASDAQ: WDC) gained 8.5% to $38.17.
- Pioneer Natural Resources Company (NYSE: PXD) surged 8.1% to $225.10 following reports suggesting Exxon Mobil Corp (NYSE: XOM) has had preliminary talks with the company about a potential acquisition.
- Micron Technology, Inc. (NASDAQ: MU) rose 7.6% to $63.02 after competitor Samsung Electronics Co said it would cut memory chip output.
- Reading International, Inc. (NASDAQ: RDIB) surged 7.4% to $23.10.
- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) gained 6.7% to $14.10.
- Comstock Resources, Inc. (NYSE: CRK) shares rose 6% to $11.01.
- Nutrien Ltd. (NYSE: NTR) gained 5.5% to $71.72 after Scotiabank upgraded the stock from Sector Perform to Sector Outperform.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.